Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Penciclovir

Penciclovir

pharmaceutical raw materials
Penciclovir structure

Penciclovir 

structure
  • CAS No:

    39809-25-1

  • Formula:

    C10H15N5O3

  • Chemical Name:

    Penciclovir

  • Synonyms:

    6H-Purin-6-one,2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)butyl]-;2-Amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)butyl]-6H-purin-6-one;BRL 39123;Penciclovir;9-[4-Hydroxy-3-(hydroxymethyl)butyl]guanine;VSA 671;Denavir;Penxiluowei;2-Amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-3H-purin-6-one;2-Amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-6,9-dihydro-1H-purin-6-one;2-Amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-3,9-dihydropurin-6-one;111790-02-4

  • Categories:

    Active Pharmaceutical Ingredients  >  Synthetic Anti-infective Drugs

Description

Penciclovir is reported to be potent against HSV types 1 and 2 with IC50 of 0.04-1.8 μg/mL and 0.06-4.4 μg/mL, respectively.

Penciclovir Basic Attributes

253.26

253.26

1312995-182-4

Characteristics

126

-1.6

Solid

1.7±0.1 g/cm3

275-277 °C

653.4°C at 760 mmHg

338.9±34.3 °C

1.749

H2O: 1.7mg/ml;0.02 M potassium phosphate: soluble 2mg/mL

-20°C Freezer

2.98X10-17 mm Hg at 25 deg C (est)

Safety Information

III

3.2

UN 1993 3/PG 3

3

36

26

UP0789400

Xi

P264, P280, P305+P351+P338, P33, P313

H319

Penciclovir Use and Manufacturing

A deuterated version of Penciclovir, an antiviral

Drug Function and Efficacy

This product is a nucleoside antiviral drug, which has an inhibitory effect on type I and type II herpes simplex viruses in vitro. In virus-infected cells, viral thymidine deoxynucleoside kinase phosphorylates this product into penciclovir monophosphate, and then cellular kinase converts penciclovir monophosphate into penciclovir triphosphate. In vitro experiments have shown that penciclovir triphosphate and deoxyguanosine triphosphate competitively inhibit herpes simplex virus polymerase, thereby selectively inhibiting the synthesis and inhibition of herpes simplex virus DNA. The generation of herpes simplex virus mutants resistant to this product is due to changes in the properties of viral thymidine deoxynucleoside kinase or DNA polymerase. The most common acyclovir-resistant virus mutants lack thymidine kinase, and they are also resistant to this product.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • API PHARMA TECH LLC

    United States United States
    Active
  • MAITHRI DRUGS PRIVATE LTD

    United States United States
    Active
  • ALEMBIC PHARMACEUTICALS LTD

    United States United States
    Active

Recommended Suppliers of Penciclovir

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.